Dr. Alton is the President and CEO of Visionary Pharmaceuticals. He implements the strategic direction of the company, oversees the technical and scientific programs and manages investor relations.

Previously Dr. Alton founded Altonyx Consulting which provided drug discovery consulting services.

He was formerly a Group Leader at Pfizer overseeing business development, academic collaborations and drug discovery.

Dr. Batova is currently faculty at the University of California, San Diego.Dr. Batova has investigated the molecular basis of T-cell acute lymphoblastic leukemia and neuroblastoma and has conducted pre-clinical evaluation of multiple target-based agents. She has authored numerous publications on these topics in peer-reviewed journals and has been invited to present her work at international meetings

Dr. Zapf is has several decades of experience in developing advanced computational algorithms to drive structure-based drug design. He has worked for several large pharmaceutical companies doing autoimmune drug discovery and holds patents on key enabling technologies.